Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Long-Term Impacts of Invasive Meningococcal Disease on Survivors and Their Caregivers in the United States and Canada.
Journal: Infectious diseases and therapy
Published: April 24, 2025
Optimal Timing of Vaccination: A Narrative Review of Integrating Strategies for COVID-19, Influenza, and Respiratory Syncytial Virus.
Journal: Infectious diseases and therapy
Published: November 08, 2024
A descriptive review on the real-world impact of Moderna, Inc. COVID-19 vaccines.
Journal: Expert review of vaccines
Published: September 13, 2024
Navigating the Evolving Landscape of COVID-19: Strategies to Increase Vaccine Confidence and Improve Vaccination Rates in the United States.
Journal: Vaccines
Published: July 05, 2024
Respiratory Virus Vaccines: Pathways to Recommendations and Enhanced Coverage for At-Risk Populations.
Journal: Infectious diseases and therapy
Published: June 03, 2024
Global Safety Assessment of Adverse Events of Special Interest Following 2 Years of Use and 772 Million Administered Doses of mRNA-1273.
Journal: Open forum infectious diseases
Published: October 02, 2023
A Call to Action: Current Challenges and Considerations for COVID-19 Vaccination in Immunocompromised Populations.
Journal: The Journal of infectious diseases
Published: August 04, 2023
Phase 3 trial to evaluate the safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine 6 months later, in at-risk adults 18-49 years of age (PNEU-DAY): A subgroup analysis by baseline risk factors.
Journal: Human vaccines & immunotherapeutics
Published: March 03, 2023
Response to Vyse et al., "A review of current data to support decision making for introduction of next generation higher valency pneumococcal conjugate vaccination of immunocompetent older adults in the UK".
Journal: Expert review of vaccines
Published: March 14, 2022
Clinical and economic burden of HPV-related cancers in the US veteran population.
Journal: Journal of medical economics
Published: February 14, 2022
Response to Eriksson et al A randomized, controlled trial comparing the immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccination to a repeated dose 13-valent pneumococcal conjugate vaccination in kidney transplant recipients.
Journal: Transplant infectious disease : an official journal of the Transplantation Society
Published: September 30, 2020
Last Updated: 09/26/2026